Hostname: page-component-7bb8b95d7b-fmk2r Total loading time: 0 Render date: 2024-09-11T22:42:51.299Z Has data issue: false hasContentIssue false
  • English
  • Français

Dantrolene for Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  29 January 2018

Jan Scott
Jan Scott*
Affiliation:
Department of Psychological Medicine, University of Newcastle upon Tyne
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 144 , Issue 1 , January 1984 , pp. 98
Copyright
Copyright © 1984 The Royal College of Psychiatrists 

References

Boules, J. M., Lecam, B., Mialon, P., Pennez, Y. & Garre, M. (1982) Hyperthermic maligne des neuroleptiques: Guérison rapide par le dantrolene. Nouv Presse Medicale (Paris), 11, 674.Google Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google Scholar
Delacour, J. L., Daoudal, P., Chapoutot, J. L. & Rocq, B. (1981) Traitment du syndrome malin de neuroleptiques par la dantrolene. Nouv Press Medicale (Paris), 10, 3572.Google Scholar
Goekopp, J. G. & Carbaat, P. A. Th. (1982) Treatment of neuroleptic malignant syndrome with dantrolene. The Lancet, ii, 49–50.Google Scholar
Hall, G. M. (1980) Dantrolene and the treatment of malignant hyperthermia. British Journal of Anaesthesia, 52, 547–9.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.